Skip to main content

ADVERTISEMENT

cost of care

Case Study
12/12/2023

Emily Sue Greenstein, MSN, APRN, CNP1; William Falone, MSN, RN, CWON2; Teresa Patterson, BSN, RN, CWON3; Katherine Cesario, MA, RN, CWOCN4; Linda Mitchell, RN, BSN, CWOCN5; Tanya Martel, DNP, FNP-BC, CWOCN6; Julie Rivera, MSN, RN, NPD-BC, CWOCN7; Maarten Vooijs, MSc8; and Sarah Norton, MSN, MBA, RN, CWCN8

Emily Sue Greenstein, MSN, APRN, CNP1...
The authors of this article examine the role that hospitals could play in the management of chronic wounds.
The authors of this article examine the role that hospitals could play in the management of chronic wounds.
The authors of this article...
12/12/2023
Wound Management & Prevention
Perspectives
08/07/2023
Elizabeth Donckels, MSPH
Nina Regenold, MSc
Theresa Schmidt, MA
Will Nolan
Scout
Don S. Dizon, MD
Tom Valuck, MD, JD
Elizabeth Donckels, MSPH, and colleagues investigate several measurement tactics to promote cancer care quality improvement for transgender individuals.
Elizabeth Donckels, MSPH, and colleagues investigate several measurement tactics to promote cancer care quality improvement for transgender individuals.
Elizabeth Donckels, MSPH, and...
08/07/2023
Journal of Clinical Pathways
High Costs of Pancreatic Enzyme Replacement Therapy Barrier to Medicare Beneficiary Drug Access
Videos
01/20/2021
Arjun Gupta, MD, discusses results from a study assessing out-of-pocket and total spending on pancreatic enzyme replacement therapy under Medicare Part D.
Arjun Gupta, MD, discusses results from a study assessing out-of-pocket and total spending on pancreatic enzyme replacement therapy under Medicare Part D.
Arjun Gupta, MD, discusses...
01/20/2021
Journal of Clinical Pathways
Real-World Treatment Patterns, HCRU in Patients With CML Achieving Later Lines of Therapy
ENGAGING EXPERTS
01/14/2021
Ehab Atallah, MD, discusses results from a study evaluating treatment patterns in patients with CML achieving later lines of therapy, and estimating the associated HCRU and costs.
Ehab Atallah, MD, discusses results from a study evaluating treatment patterns in patients with CML achieving later lines of therapy, and estimating the associated HCRU and costs.
Ehab Atallah, MD, discusses...
01/14/2021
Journal of Clinical Pathways
HCRU, Costs With CAR-T Therapy Compared to Transplantation for DLBCL
Videos
12/17/2020
Karl Kilgore, PhD, discusses study results that showed greater HCRU and costs with CAR-T therapy than transplantation for patients with relapsed/refractory DLBCL.
Karl Kilgore, PhD, discusses study results that showed greater HCRU and costs with CAR-T therapy than transplantation for patients with relapsed/refractory DLBCL.
Karl Kilgore, PhD, discusses...
12/17/2020
Journal of Clinical Pathways